AMPEL BioSolutions' Breakthrough Predicts Drug Options to Slow End Stage Renal Disease AMPEL BioSolutions' Breakthrough Predicts Drug Options to Slow End Stage Renal Disease
Third Annual Science2Startup (S2S)™ Symposium on May 3, 2023 Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors Third Annual Science2Startup (S2S)™ Symposium on May 3, 2023 Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors
Charlottesville Startup Among Top 25 Healthcare Technology Leaders of Virginia Charlottesville Startup Among Top 25 Healthcare Technology Leaders of Virginia
$100M donor gift to launch U.Va. biotech institute $100M donor gift to launch U.Va. biotech institute
ICON acquisition creates world-leading healthcare intelligence and clinical research organization. ICON acquisition creates world-leading healthcare intelligence and clinical research organization.
Rivanna's Accuro Shows Statistically Significant Efficacy And Safety For Combined Spinal- Epidural Anesthesia Rivanna's Accuro Shows Statistically Significant Efficacy And Safety For Combined Spinal- Epidural Anesthesia
Kerry extends growing probiotic line with marketing deal covering spore forming ingredient Kerry extends growing probiotic line with marketing deal covering spore forming ingredient
Novel Small Molecule Technology Reverses Life-Threatening Opioid-Induced Respiratory Depression Novel Small Molecule Technology Reverses Life-Threatening Opioid-Induced Respiratory Depression
HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout
